Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.95 +0.00 (+0.04%)
As of: Sep 30, 2026 · 3:59 PM EDT

Lineage Cell Therapeutics (LCTX) Tax Provisions (2014 - 2023)

Updated

Lineage Cell Therapeutics (LCTX) posted Tax Provisions of -$5.28 million for FY2025.

Analysis

Lineage Cell Therapeutics (LCTX) Tax Provisions (2014 - 2023) Analysis & Trends

Since FY2018, Lineage Cell Therapeutics has reported Tax Provisions for 6 years.

  • The FY2025 figure stands as the lowest annual Tax Provisions since FY2019.
  • Business Quant data shows LCTX's Tax Provisions at -$1.8 million in FY2023 and $541,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.21 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 662.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -291.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 242.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 292.00 Mn
10 Lineage Cell Therapeutics 242.79 Mn 41.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -1.80 Mn
Sep 30, 2022 541,000.00
Sep 30, 2021 -1.01 Mn
Dec 31, 2019 -14.01 Mn
Sep 30, 2019 1.00 Mn
Jun 30, 2019 1.22 Mn
Mar 31, 2019 4.38 Mn
Sep 30, 2014 -2.31 Mn
Jun 30, 2014 -1.51 Mn
Mar 31, 2014 -1.35 Mn
API Access

Lineage Cell Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=LCTX&period=max&api_key=YOUR_API_KEY